Tech Company Inital Public Offerings
Personalis IPO
Operating out of Menlo Park, Personalis is now a public company.
Transaction Overview
Company Name
Announced On
6/19/2019
Transaction Type
IPO
Amount
$134,300,000
Proceeds Purpose
We currently intend to use the net proceeds we receive from this offering for expanded research and development, infrastructure expansion, facilities expansion, headcount growth, sales and marketing expenditures, public company costs, capital expenditures, and working capital. We cannot specify with certainty all of the particular uses for the remaining net proceeds to us from this offering.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1330 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Personalis (Nasdaq: PSNL) combines world class expertise in the technology of genome sequencing and interpretation with an extensive track record of peer-reviewed publications and commercial success.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John West
Chief Scientific Officer
Richard Chen
Vice President
Christian Haudenschild
VP - Engineering
Lloyd Hsu
VP - Finance
Carol Tillis
VP - Marketing
Rena McClory
VP - R & D
Xavier Paliard
VP - Sales
Michael Fitzpatrick
Browse more venture capital transactions:
Prev: 6/19/2019: SafeAI venture capital transaction
Next: 6/19/2019: Cleave Biosciences venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs